Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying results 1 - 12 of 29
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - FR

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - FR

PDF
View
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - GE

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - GE

PDF
View
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - CZ

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - CZ

PDF
View
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - GE

EASL Policy Statement on Hepatitis C Elimination - GE

PDF
View
Public Health and Advocacy
EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - RU

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - RU

PDF
View
Public Health and Advocacy
EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - CZ

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - CZ

PDF
View
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

PDF
View
COVID-19 and the liver
EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Transplant Recipients

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF
View
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - SP

EASL Policy Statement on Hepatitis C Elimination - SP

PDF
View
Public Health and Advocacy
EASL Policy Statement on Obesity is Feeding the Rise in Non-Alcoholic Fatty Liver Disease (NAFLD) across Europe

EASL Policy Statement on Obesity is Feeding the Rise in Non-Alcoholic Fatty Liver Disease (NAFLD) across Europe

PDF
View
Public Health and Advocacy
EASL Policy Statement on Liver Disease and Migrant Health

EASL Policy Statement on Liver Disease and Migrant Health

PDF
View
Public Health and Advocacy
EASL Policy Statement on Screening of blood donations for hepatitis E virus (HEV)

EASL Policy Statement on Screening of blood donations for hepatitis E virus (HEV)

PDF
View